Sign In
Buy IONS
$73.82
+0.85 (+1.16%)
At Close: Jun 03, 2026
7 F-Rated Stocks to Avoid for the Rest of 2021
10:52am, Monday, 02'nd Aug 2021
In a churning market like this, you want to steer clear of stocks that are floundering. Here are sevens stocks to avoid today.
Ionis completes enrollment in pivotal NEURO-TTRansform study of eplontersen
07:05am, Thursday, 29'th Jul 2021
CARLSBAD, Calif., July 29, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapies, today announced it has completed enrollment of NEURO-TTRansform, the
Biogen and Ionis report positive topline clinical data on investigational Alzheimer's disease treatment at AAIC
04:35pm, Monday, 26'th Jul 2021
CAMBRIDGE, Mass. and CARLSBAD, Calif.
5 Mid-Cap Healthcare Stocks You'll Want on Your Radar for the 2nd Half of 2021
07:01am, Friday, 23'rd Jul 2021
These biotech stocks could have great long-term potential.
Ionis to hold second quarter 2021 financial results webcast
07:05am, Wednesday, 21'st Jul 2021
CARLSBAD, Calif., July 21, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Wednesday, August 4 th at 11:30 a.m.
Ionis (IONS) Inks Deal With Bicycle Therapeutics for LICA Drugs
11:36am, Wednesday, 14'th Jul 2021
Ionis (IONS) signs a deal with Bicycle Therapeutics to incorporate the latter's optimized Bicycle peptides into its LICA delivery platform.
Bicycle, Ionis To Develop Targeted Oligonucleotide Therapeutics
08:06am, Tuesday, 13'th Jul 2021
Bicycle Therapeutics plc (NASDAQ: BCYC) announced that Ionis Pharmaceuticals Inc (NASDAQ: IONS) has exercised its option and entered into an exclusive worldwide license and collaboration agreement
New Strong Sell Stocks for July 8th
09:47am, Thursday, 08'th Jul 2021
CLPR, IONS, RAD, TFFP, and VNCE have been added to the Zacks Rank #5 (Strong Sell) List on July 8, 2021
Can These 2 Beaten-Down Biotechs Rebound? Cathie Wood Thinks So.
06:30am, Tuesday, 06'th Jul 2021
Recent trial disappointments scared off some investors.
Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition
02:24am, Wednesday, 30'th Jun 2021
Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition
Ionis Pharmaceuticals Stock Looks Attractive At $37
08:30am, Wednesday, 23'rd Jun 2021
We believe that the stock price of Ionis Pharmaceuticals, a biotech company that specializes in discovering and developing RNA-targeted therapeutics, is undervalued at current levels of under $37. ION
3 Stocks Wall Street Thinks Will Skyrocket 50% or More
06:02am, Saturday, 19'th Jun 2021
Analysts view all three as rebound candidates.
Ionis' Chief Scientific Officer C. Frank Bennett, Ph.D.
04:05pm, Monday, 14'th Jun 2021
CARLSBAD, Calif., June 14, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced that Executive Vice President and Chief Scientific Officer C.
Ionis' antisense therapies in ATTR amyloidosis to be featured at 2021 PNS Annual Meeting
06:05pm, Thursday, 10'th Jun 2021
CARLSBAD, Calif., June 10, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapies, today announced that multiple presentations highlighting advances in
Why Is Ionis Pharmaceuticals (IONS) Down 7% Since Last Earnings Report?
12:48pm, Friday, 04'th Jun 2021
Ionis Pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock?
